For high-volume metastatic CRPC to bone, what dosing schedule of zoledronic acid or denosumab do you use?
With the data primarily in breast cancer supporting q3 month zoledronate rather than monthly dosing, is this reasonable to do in mCRPC?
Community PollStarted
What dosing schedule do you use for bone modifying agents for mCRPC with high volume bone metastasis?
50 physicians have voted
Join Mednetto vote and see how they answered.